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Development of CD8+ T cell (CTL) immunity or toler-
ance is linked to the conditions during T cell priming.
Dendritic cells (DCs) matured during inflammation
generate effector/memory T cells, whereas immature
DCs cause T cell deletion/anergy. We identify a third
outcome of T cell priming in absence of inflammation
enabled by cross-presenting liver sinusoidal endo-
thelial cells. Such priming generated memory
T cells that were spared from deletion by immature
DCs. Similar to central memory T cells, liver-primed
T cells differentiated into effector CTLs upon antigen
re-encounter on matured DCs even after prolonged
absence of antigen. Their reactivation required
combinatorial signaling through the TCR, CD28,
and IL-12R and controlled bacterial and viral infec-
tions. Gene expression profiling identified liver-
primed T cells as a distinct Neuropilin-1+ memory
population. Generation of liver-primed memory
T cells may prevent pathogens that avoid DCmatura-
tion by innate immune escape from also escaping
adaptive immunity through attrition of the T cell
repertoire.INTRODUCTION
Generation of CD8+ T cell (cytotoxic T lymphocyte [CTL]) immu-
nity occurs through priming of naive CD8+ T cells by professional
antigen-presenting cells (APCs) such as dendritic cells (DCs)
in secondary lymphatic tissues (Takada and Jameson, 2009;Zhang and Bevan, 2011). Appropriate innate immune stimulation
causes DC maturation into immunogenic APCs that can cross-
prime naive CD8+ T cells, causing differentiation into effector
and memory T cells (Harty and Badovinac, 2008; Kaech et al.,
2002b; Kurts et al., 2010; Parish et al., 2009). In the absence of
innate immune stimulation, immature APCs cross-presenting
exogenous antigens induce peripheral tolerance characterized
by anergy, suppression, or clonal deletion of T cells (Redmond
and Sherman, 2005; Steinman et al., 2003). Alternatively,
presentation of self-antigens by stromal cells in lymphatic tissue
also contributes to peripheral T cell deletion (Gardner et al.,
2008). Surviving tolerant self-antigen specific T cells generated
under noninflammatory conditions retain their functional nonres-
ponsiveness even after challenge with pathogens (Schietinger
et al., 2012). While innate immune activation and inflammation
are a precondition for induction of adaptive immunity, it has
become clear that some infectious microorganisms such as
hepatitis viruses employ stealth mechanisms to escape or pre-
vent induction of innate immunity while disseminating viral anti-
gens systemically (Protzer et al., 2012). Cross-presentation
under noninflammatory conditions by immature DCs threatens
to elicit peripheral tolerance in antigen-specific CTLs and
thereby facilitate viral persistence.
Here, we report on the existence of a third outcome of naive
CD8+ T cell priming in addition to immunogenic priming by
matured DCs and tolerogenic priming by immature DCs. This
third way of T cell priming is enabled by liver sinusoidal endothe-
lial cells (LSECs) cross-presenting circulating exogenous antigen
during noninflammatory conditions. Once primed by LSECs,
T cells were not deleted any more by antigen-presenting
immature DCs. Although priming by LSECs induces T cell
nonresponsiveness toward isolated T cell receptor (TCR) signal-
ing (Diehl et al., 2008; Limmer et al., 2000; Schurich et al.,
2010), liver-primed T cells were not terminally committed to theirCell Reports 3, 779–795, March 28, 2013 ª2013 The Authors 779
Figure 1. Naive CD8+ T Cells Primed by Cross-Presenting LSECs in the Absence of Inflammation Survive and Are Reactivated by
Matured DCs
(A) Surface phenotype and proliferation of adoptively transferred CD45.1+ CD8+ OT-I T cells (13 106 cells/mouse) 4 days after antigen-specific priming by LSECs
in CD45.2+ (bm1/ C57BL/6) chimeric mice in vivo (see Figure S1).
(legend continued on next page)
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nonresponsive state but rather acquired a differentiation state
that enabled them to generate effector T cells under inflamma-
tory conditions. Similar to central memory T cells, reactivation
of liver-primed T cells for generation of protective effector
CTLs required combinatorial stimulation through CD28 and
interleukin (IL)-12 in addition to TCR signaling. Our results define
a liver-primed memory T cell population that is generated by
nonprofessional APCs, which rescues T cells from tolerization
by immature DCs and enables the subsequent induction of path-
ogen-specific CTL immunity.
RESULTS
Naive CD8+ T Cells Primed by Cross-Presenting LSECs
in the Absence of Inflammation Survive and Can Be
Reactivated by Matured DCs
We investigated the fate of T cells stimulated by LSEC (liver-
primed T cells) in vivo using an established chimeric mouse
model, in which cross-presentation occurs by liver-resident
LSECs but not bone-marrow-derived DCs (von Oppen et al.,
2009). In this model (Figure S1A), radiation-resistant LSECs effi-
ciently cross-present nonself antigen to circulating naive CD8+
T cells, whereas no cross-presentation is observed by profes-
sional APCs in spleen or liver (von Oppen et al., 2009), which
correlates with H-2Kb expression in the chimeras that is detected
on LSECs but not bone-marrow-derived cells (Figures S1B and
S1C). To study the consequences of cross-presentation of
soluble proteins by LSECs to naive CD8+ T cells under nonin-
flammatory conditions, we adoptively transferred naive car-
boxyfluorescein-diacetate-succinimidyl-ester (CFSE)-labeled
CD45.1+ OVA-specific TCR transgenic T cells (OT-I) into these
chimeras. Four days after injection of soluble LPS-free OVA,
naive OT-I T cells had proliferated and upregulated the activation
marker CD44 while expressing CD62L at high levels (Figure 1A).
T cell proliferation was not observed in the absence of antigen
excluding homeostatic proliferation as a cause. As CD8+ T cell
priming under noninflammatory conditions can result in clonal
deletion (Mueller, 2010; Steinman et al., 2003), we investigated(B) Adoptive transfer of 5 3 105 OT-I T cells and determination of total numbe
conditions by LSECs (soluble OVA in [bm1/ C57BL/6] chimeric animals) or t
C57BL/6 mice).
(C) In-vitro-generated liver-primed OT-I T cells (d4 after priming) were analyzed
loaded matured DCs. IFN-g expression within viable T cells was determined a
stimulated with PMA/ionomycin for 20 hr served as control.
(D and E) Recombinant CEA protein (2 mg/mouse) was injected i.v. into HLA-A*20
identified by HLA-A*201 dextramer staining loaded with the CEA-specific peptid
(D–G) These CEA-specific CD8+ T cells were analyzed for (D) surface marker exp
restimulation by PMA/ionomycin. CEA-specific CTLs isolated 2 weeks after DNA
granzyme B mRNA (F) and protein (G) in OT-I T cells after coculture with OVA
experiments is shown.
(H) Antigen-specific cytotoxicity; naive T cells cultured on LSECs in absence of
independent experiments.
(I) Principal component analysis based on most variably expressed genes (n = 61
matured DC-primed (n = 5) OT-I T cells (d4 after in vitro priming).
(J) Following transfer of naive CD90.1+ OT-I T cells (106 cells/mouse), detecti
(400 mg/mouse) or PBS in CD90.1+ T cells in the livers of (bm1/ C57BL/6) m
compared to isotype control and (I) percentage of granzyme B+ among CD8+CD
Data are representative of two to five independent experiments (A–H, and J and
See also Figure S1.the fate of liver-primed T cells and compared it to that of naive
T cells primed by immature DCs, i.e., following injection of
OVA coupled to DEC205 into C57BL/6 mice (Bonifaz et al.,
2002). As expected, T cell numbers were reduced 7 days
after priming by immature DCs (Figure 1B), which is compatible
with DEC205-OVA-dependent deletion through DC-mediated
cross-tolerance. Of note, OVA-DEC205 was not cross-pre-
sented by LSECs (Figure S1D), which may be related to the
absence of DEC205 expression from LSECs (data not shown)
and the very low antigen-concentration used. Seven days after
priming by LSECs, however, we found high numbers of viable
T cells in blood and spleen (Figure 1B), indicating that LSEC
priming did not induce T cell elimination. These results demon-
strate that T cell priming by LSECs or by immature DCs leads
to different outcomes. Consistent with our previous reports
(Diehl et al., 2008; Limmer et al., 2000), we found that T cells at
d4 after priming by LSECs failed to respond to stimulation via
TCR triggering or phosphomyristolic acid (PMA)/ionomycin
treatment (Figure 1C). However, when liver-primed T cells recog-
nized their antigen onmaturedDCs they started to produce inter-
feron (IFN)-g (Figure 1C). CD8+ T cells with a different specificity
(carcino-embryonic-antigen [CEA] specific) but similar pheno-
type, i.e., CD62L+CD44+ T cells that did not produce IFN-g
upon restimulation, were also found in HLA-A2 transgenic mice
upon repeated i.v. injection of recombinant CEA (Figures 1D
and 1E), indicating that they are derived fromCEA cross-presen-
tation by LSECs (Ho¨chst et al., 2012). Collectively, these results
indicated that the nonresponsiveness of liver-primed T cells
toward TCR signaling was reversible and thereby distinct from
the ultimately committed nonresponsiveness observed in toler-
ized T cells (Schietinger et al., 2012). This questioned our earlier
reports that liver-primed T cells were tolerant (Diehl et al., 2008;
Limmer et al., 2000; Schurich et al., 2010) and rather indicated
that their nonresponsiveness is part of a as-yet-unknown T cell
differentiation state.
The observed lack of deletion and the ability of matured DCs to
evoke IFN-g production in liver-primed T cells led us to charac-
terize the early steps in their differentiation in vitro. Expression ofrs of OT-I T cells 7 days after antigen-presentation during noninflammatory
olerogenic immature DCs (OVA coupled to anti-DEC205: DEC205-P3UOrv in
for IFN-g production after stimulation by PMA/ionomycin, anti-CD3, or OVA-
fter 20 hr by intracellular staining. OT-I T cells primed by matured DCs and
1 mice every second day for 14 days. Splenic CEA-specific CD8+ T cells were
e YLSGANLNL.
ression and (E) IFN-g production determined by intracellular staining after 4 hr
vaccination with pGT64 CEA plasmid served as positive control. Analysis of
-loaded LSECs or splenic, matured DCs in vitro. One of three independent
OVA served as control. Mean ±SD is shown. Data are representative of three
6 genes, FDR 10%, p < 0.000005) in naive (n = 5), liver-primed T cells (n = 4), or
on of granzyme B protein expression 18 hr after injection of LPS-free OVA
ice or C57BL/6 mice. Representative flow cytometric graphs of granzyme B
90.1+ OT-I T cells.
K).
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Figure 2. Liver-Primed CD8+ T Cells Re-express CD62L and Migrate to Secondary Lymphoid Organs
(A) Time kinetics of CD62L expression by OT-I T cells primed in vitro by LSECs or matured DCs. Numbers on the right y axis show percentage of CD62L+ T cells.
(B) Migration of OT-I T cells toward CCL19 or CCL21 in a transwell assay.
(C and D) After T cell priming in vitro, 1:1 ratios of differentially labeled liver-primed T cells (red) and naive OT-I T cells (green) or liver-primed (red) and OT-I T cells
primed by mature DCs (green) (total of 5 3 106 cells/animal) were adoptively transferred into C57BL/6 mice. (C) T cell detection in the T cell zones of secondary
lymphoid organs identified by anti-CD3 staining (blue). One representative image of at least ten T cell zones per organ is shown.
(legend continued on next page)
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granzyme B is important for antigen-specific CTL cytotoxicity
(Barry and Bleackley, 2002). We found that T cells primed by
matured DCs that developed into effector CTLs expressed gran-
zyme B and showed prominent cytotoxicity 4 days after priming
(Figures 1F–1H). Liver-primed T cells neither expressed gran-
zyme B nor showed cytotoxicity at this time point (Figures 1F–
1H) consistent with our previous findings (Limmer et al., 2000).
However, at day 1 (d1) after priming liver-primed T cells strongly
expressed granzyme B and were highly cytotoxic (Figures 1F–
1H). This indicates that liver-primed T cells transiently became
effector cells before CTLs primed by matured DCs gained their
full effector capacity, but subsequently lost their ability to elicit
direct effector function upon TCR triggering (see Figure 1C).
Global gene expression profiling followed by principle compo-
nent analysis substantiated that liver-primed T cells were dif-
ferent from both naive T cells and CTLs primed by matured
DCs (Figure 1I).
To characterize whether naive T cell stimulation by cross-pre-
senting LSECs occurred also during direct competition with
priming by immature DCs in vivo, we challenged wild-type
C57BL/6 mice after naive CD90.1+ OT-I T cell transfer with
LPS-free OVA, where both LSECs and immature DCs had
the chance to interact with naive OT-I T cells. Eighteen hours
after OVA application, we detected a significant population of
CD90.1+ granzyme B+ T cells in the liver (Figure 1J), suggesting
that granzymeB expression was induced by LSECs. Induction of
granzyme B in T cells through cross-presenting LSECs was
confirmed in chimeric mice (Figure 1J). The percentage of
granzyme B+ cells among total CD90.1+ OT-I-derived T cells
was similar in OVA-challenged chimeric and C57BL/6 mice
(Figure 1K), indicating that competition with cross-presenting
DCs did not modify the ability of LSECs to interact with naive
CD8+ T cells and to induce granzyme B expression. Taken
together, these results identify a third way of T cell priming in
the absence of inflammation where T cells are not deleted but
undergo a temporary activation phase without differentiating
into effector CTLs. Because liver-primed T cells expressed the
lymphoid homing receptor CD62L, which is employed by naive
T cells and a subset of memory T cells (central memory T cells
[TCMs]) to localize to lymphatic tissue, we next investigated
whether liver-primed T cells migrated into spleen and lymph
nodes.
Lymphoid Homing of Liver-Primed T Cells
Time kinetic analysis revealed a rapid re-expression of CD62L
in liver-primed T cells but not in CTLs primed by immunogenic
matured DCs in vitro (Figure 2A). Because T cell entry into
lymph nodes requires CD62L and migration toward the chemo-
kines CCL19/CCL21 (Fo¨rster et al., 1999), we next investigated
their chemotactic behavior. Both liver-primed T cells and naive(E and F) Quantification of T cell localization within T cell zones in lymph nodes a
T cells into (bm1/C57BL/6) chimeric animals or C57BL/6mice and injection of s
d7 after injection of OVA (E), total numbers of liver-primed (CFSElow) CD45.1+ OT-
incorporation were analyzed in liver, spleen, and inguinal lymph nodes. BrdU wa
(G) Naive CD45.1+ OT-I T cells or CD45.1+ OT-I T cells isolated from liver 3 days a
CD103 expression versus appropriate isotype controls (gray shaded area).
Data are representative of at least two separate experiments with three to four mT cells migrated efficiently toward CCL19/21 in a transwell
assay, whereas effector T cells primed by matured DCs did not
(Figure 2B).
To address the relevance of these findings for in vivo migra-
tion, we directly compared liver-primed T cells to naive T cells
or effector CTLs primed by matured DCs by cotransfer of differ-
entially fluorochrome-labeled cells. Liver-primed T cells similar
to naive CD8+ T cells migrated to lymphatic tissue and localized
to the T cell zones in lymph nodes and spleen, whereas effector
CTLs did not locate to the same compartment (Figures 2C and
2D). To verify T cell migration to lymphatic organs after in vivo
priming by LSECs, we used the chimeric mouse model, where
cross-presentation is restricted to LSECs (see Figure S1; von
Oppen et al., 2009). We compared the numbers of proliferating
(CFSElow) OT-I-derived CD45.1+ T cells from d2 with those at
d7 after in vivo priming by LSECs cross-presenting OVA.
Whereas the numbers of CD45.1+ CFSElow T cells in the liver
did not differ between d2 and d7, there was an increase of
CD45.1+ CFSElow T cells in spleen and lymph nodes at d7 (Fig-
ure 2E). Bromodeoxyuridine (BrdU) incorporation was mainly
observed in CD45.1+ T cells in the liver at d2 after OVA challenge,
whereas at later time points or in CD45.1+ T cells in lymphatic
tissue little if any BrdU incorporation was observed (Figure 2F).
This indicates relocation of T cells to lymphatic tissues after local
priming in the liver. Consistent with egress of liver-primed T cells
from the liver in vivo, we further observed downregulation of
CD103, which is involved in retention of T cells within peripheral
organs (Figure 2G). Thus, priming by LSECs in the liver under
noninflammatory conditions does not cause T cell deletion but
generates an antigen-experienced T cell population that enters
lymphatic tissues early after priming.
Memory-like Properties of Liver-Primed T Cells
Among the T cells primed initially by matured DCs during inflam-
mation, some express CD62L and locate to lymph nodes such as
early TCMs, which then increase in numbers over time (Harty and
Badovinac, 2008; Wakim and Bevan, 2010). As liver-primed
T cells rapidly re-expressed CD62L after priming and localized
to lymphatic tissue, we reasoned that they might have a similar
distribution to TCMs in vivo and directly compared lymphatic
tissue localization of OT-I-derived T cells at d7 after priming by
LSECs with that of OT-I-derived TCMs or effector memory
T cells (TEMs) at >d45 postinfection with Listeriamonocytogenes
(L.m.)-OVA. Liver-primed T cells localized to lymph nodes and
spleen similar to TCMs but not TEMs (Figure 3A). This led us to
examine whether liver-primed T cells share further characteris-
tics with TCMs.
Memory T cell generation and differentiation is regulated by
complex transcriptional programs (Angelosanto and Wherry,
2010; Rutishauser and Kaech, 2010), in which the two T-boxnd spleen (E). Adoptive transfer of 1 3 106 naive CFSE-labeled CD45.1+ OT-I
oluble OVA into (bm1/C57BL/6) or PBS into C57BL/6 mice (control). At d2 or
I T cells and (F) total numbers of proliferating CD45.1+ T cells assessed by BrdU
s injected i.p. 20 hr before analysis on d2 or d7, respectively.
fter priming by LSECs in (bm1/ C57BL/6) chimeric animals were analyzed for
ice per group (C–F) are shown; ns, not significant.
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Figure 3. Liver-Primed T Cells Have Memory-like Functions and Differentiate into Effector T Cells upon Infection
(A) In vivo distribution of CD45.1+ OT-I T cells 7 days after priming by LSECs in (bm1 / C57BL/6) chimeric animals or > d45 after L.m.-OVA infection in
C57BL/6 mice.
(legend continued on next page)
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transcription factors T-bet and Eomesodermin (Eomes) play key
roles (Intlekofer et al., 2005; Rao et al., 2010).We found that liver-
primed T cells similar to TCMs expressed high levels of Eomes
(Figure 3B). However, whereas TCMs expressed T-bet at low
levels, liver-primed T cells completely lacked T-bet expression
when examined ex vivo (Figure 3B) or in vitro (Figure S2A).
T cell factor 1 (TCF-1), a transcription factor required for memory
T cell differentiation that controls Eomes expression (Zhou et al.,
2010), was expressed at high levels in liver-primed T cells
compared to effector T cells primed by matured DCs (Fig-
ure S2B). Furthermore, Bcl-6, a transcription factor that is
important for memory T cell differentiation (Ichii et al., 2002),
was upregulated in liver-primed T cells compared to naive
T cells (Figure S2C). In contrast, the transcription factor Blimp-1
that is associated with effector cell differentiation (Kallies et al.,
2009; Rutishauser et al., 2009) and T cell exhaustion (Shin
et al., 2009) was not expressed in liver-primed T cells (Fig-
ure S2B). Finally, liver-primed T cells expressed the cytokine
receptors CD127, CD122, and CD27 (Figure 3B) and responded
with increased survival to signaling from the gc-cytokines IL-7/
IL-15 in vitro (Figure 3C). There were no major differences in
the phenotypic profile, frequency of granzyme B+, or IFN-g-
producing liver-primed T cells isolated from the liver compared
to those isolated from the spleen of chimeric mice at d7 after
OVA application (Figure S3), suggesting that the surface and
functional phenotype remained stable in liver-primed T cells irre-
spective of their tissue localization. Thus, there is remarkable
similarity between liver-primed T cells and TCMs in the expres-
sion of transcription factors known to be associated with
memory T cell differentiation and their ability to respond to sur-
vival signals.
Like Central Memory T Cells, Liver-Primed T Cells Can
Be Reactivated and Generate Effector CTLs during
Infection
The absence of T-bet expression on d4 in liver-primed T cells
may explain their lack of direct effector function upon isolated
TCR triggering (Cruz-Guilloty et al., 2009). The similarities to
TCMs in expression of transcription factors determining memory
T cell differentiation and IFN-g production upon reactivation by
matured DCs (see Figure 1C) indicated that liver-primed T cells
might not be terminally committed to their nonfunctional state
but possess the potential to give rise to effector T cells (Intlekofer
et al., 2007; Joshi et al., 2007; Rutishauser and Kaech, 2010).
To test for such plasticity, we adoptively transferred either
CD45.1+ liver-primed OT-I T cells sorted from the spleen of
(bm1/ C57BL/6) chimeric mice or splenic OT-I-derived TEMs
or TCMs sorted from mice at d45 postinfection with L.m.-OVA(B) Analysis of surface marker expression and intracellular staining of T-box trans
TEMs. Representative flow cytometric analyses from at least four independent e
(C) In-vitro-generated liver-primed T cells were obtained at d4 and incubated with
Error bars show mean ±SD. Data are representative of three independent exper
(D and E) Wild-type C57BL/6 mice were challenged with AdOVA or AdGFP (5
FACSorted CD45.1+ OT-I-derived liver-primed OT-I cells, TCMs, or TEMs (see F
were analyzed for CD45.1+CD62L effector OT-I cells and total numbers of IFN-
(F) Transfer of 53 103 in-vivo-generated CD45.1+ liver-primed OT-I cells and chal
frequency of CD45.1+CD8+ T cells was determined in spleen or liver at d5 after i
See also Figures S2 and S3.into CD45.2+ recipients and infected them with an adenovirus
expressing OVA (AdOVA). We excluded transfer of contami-
nating naive T cells within liver-primed T cells by FACSorting
for CD44hiCD62Lhi T cells that had proliferated (CFSElow) (Fig-
ure S3D). Five days after AdOVA infection, liver-primed T cells
expanded extensively, downregulated CD62L, and produced
IFN-g upon restimulation (Figures 3D and 3E). This recall
response was antigen specific and did not occur after AdGFP
infection excluding bystander activation of transferred cells
due to virus-induced inflammation (Figure 3D). The magnitude
of the recall response generated by liver-primed T cells within
5 days after initial infection was similar to that elicited by the
same number of transferred TCMs (Figure 3E). As expected,
TEMs did not generate a prominent recall response (Bouneaud
et al., 2005; Wherry et al., 2003). Even when liver-primed
T cells remained without antigen contact for 38 days in vivo,
we observed effector T cell generation following AdOVA infection
(Figure 3F), pointing to another similarity with memory T cells,
i.e., survival in the absence of antigen. These results demon-
strate that liver-primed T cells were not terminally committed
to their nonresponsive state that was initially reported (Diehl
et al., 2008; Limmer et al., 2000; Schurich et al., 2010) in contrast
to self-antigen specific tolerant T cells that retain their nonfunc-
tional state even during infection (Schietinger et al., 2012).
Priming by LSECs rather induced a differentiation state in
T cells similar to TCMs where they gained the potential to
generate effector T cell responses.
Molecular Requirements for Effector CTL Generation
from Liver-Primed T Cells
Our results raised the question how reactivation of liver-primed
T cells was achieved. The fact that liver-primed T cells produced
IFN-g after stimulation by antigen-presenting matured DCs (see
Figure 1C) indicated that signals beyond TCR stimulation were
necessary for their activation. We therefore introduced costi-
mulatory signals for reactivation of liver-primed T cells and
substituted matured DCs with aCD3/28-coated beads as artifi-
cial APCs combined with different proinflammatory cytokines.
Liver-primed T cells produced IFN-g upon reactivation with
combinatorial stimulation with aCD3/28+IL-12 but not any other
combination thereof (Figure 4A). Costimulation by IL-12 could
be partially replaced by IFN-a but not other cytokines such as
IL-2 (Figures S4A and S4B), demonstrating a fundamental differ-
ence of liver-primed T cells to IL-2-responsive anergic T cells
(Schwartz, 2003). In order to determine whether IL-12 and poten-
tially type I IFN mediated the reactivation of liver-primed T cells
throughmatured DCs (see Figure 1C), we used antagonistic anti-
bodies during coculture ofmatured DCswith liver-primed T cells.cription factors of in-vivo-generated CD90.1+ liver-primed T cells, TCMs, and
xperiments with three to five mice per group are shown.
IL-7 (10 ng/ml) and/or IL-15 (10 ng/ml) and analyzed for T cell survival over time.
iments.
3 106 pfu/mouse i.v.) after adoptive transfer of 1,000 in-vivo-generated and
igure S3D). Seven days after AdOVA or AdGFP infection, splenic CD8+ T cells
g-producing CD45.1+ OT-I cells after 4 hr of peptide restimulation.
lenge with AdOVA or AdGFP (53 106 pfu/mouse) at d1 or d38 posttransfer. The
nfection.
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Figure 4. Combinatorial Stimulation of Liver-Primed T Cells Is Necessary for Effector T Cell Generation
(A–F) In-vitro-generated liver-primed T cells (d4 after priming) were analyzed for effector T cell functions after stimulation. Data are representative of three to five
independent experiments. (A and B) Combinatorial stimulation for 20 hr and determination of IFN-g expression in supernatant by ELISA (A) or frequency of IFN-g-
producing cells after additional 4 hr restimulation by PMA/ionomycin (B). (C) In-vitro-generated liver-primed T cells were stimulated with aCD3, aCD3/28, or
aCD3/28+IL-12 for 10 hr, and total mRNA was isolated and analyzed by semiquantitative RT-PCR for expression levels of tbx21 and eomes. Data show
mean ±SEMof four independent experiments. (D) In-vitro-generated liver-primed T cells were stimulated as indicated and suppliedwith EdU-containingmedium,
and 20 hr later living T cells were analyzed for EdU incorporation. Representative data from one of three independent experiments are shown. (E) T cell expansion
over time and specific cytotoxicity analyzed 72 hr after indicated in vitro stimulation (F).
(G and H) Transfer of identical numbers of in-vivo-generated OT-I-derived liver-primed T cells (G) or identical numbers of TCMs obtained >d45 after L.m.-OVA
infection (H) into wild-type, cd80/86/, or il12p35/ mice followed by AdOVA challenge. TEMs from the same animals served as a control in (H). Five days
postinfection, total numbers of OT-I T cells in spleen that produced IFN-g after PMA/ionomycin stimulation relative to 1,000 initially transferred OT-I T cells.
Data are representative of two independent experiments with three to four mice per group. n.d., not detected.
See also Figure S4.Clearly, blockade of IL-12 or the type I IFN receptor (IFNAR1)
reduced IFN-g expression in liver-primed T cells cocultured
with matured DCs, whereas only blockade of type I IFN impaired
the generation of granzyme B+ CTLs (Figures S4C and S4D). In
addition to the crucial role of IL-12 and type I IFN, further costi-786 Cell Reports 3, 779–795, March 28, 2013 ª2013 The Authorsmulatory molecules or cytokines known to induce IFN-g expres-
sion and CTL effector function may also be involved.
To analyze how many liver-primed T cells gained the capacity
to produce IFN-g after combinatorial stimulation, we challenged
these cells with PMA/ionomycin. Under these conditions, more
than 70% of liver-primed T cells reactivated initially by aCD3/
28+IL-12-produced IFN-g (Figure 4B). The development into
cytokine producing cells did not depend on TCR affinity,
because liver-primed T cells bearing a high (OT-I T cells) or inter-
mediate (DES-TCR) affinity TCR produced IFN-g equally well
after combinatorial stimulation (data not shown). The combinato-
rial stimulation led to upregulation of tbx21 (T-bet) and downre-
gulation of eomes mRNA in liver-primed T cells (Figure 4C),
suggesting the onset of effector CTL generation (Takemoto
et al., 2006). Hence, we investigated the relevance of these
signals for T cell expansion and gain of CTL effector function.
Whereas aCD3/28 stimulation sufficed for proliferation and
expansion of liver-primed T cells (Figures 4D and 4E), acquisition
of CTL effector function required additional IL-12 signaling
(Figure 4F). CD28 and IL-12 signaling were also essential for
reactivation of liver-primed T cells in vivo during viral infection,
because liver-primed T cells did not generate effector CTLs after
transfer into cd80/86/ or il12p35/mice (Figure 4G). A similar
dependence on combinatorial stimulation for generation of CTLs
wasobserved during bacterial infectionwith Listeria (Figure S4E).
The emergence of some effector CTLs detected after transfer of
liver-primed T cells into il12p35/micemay be explained by the
compensatory function of type I IFN, which is likely elicited
during viral infection and can partially replace IL-12.
We expected that TCMs unlike liver-primed T cells would not
need costimulatory signals for effector T cell generation upon
antigen re-encounter. However, TCMs adoptively transferred
into cd80/86/ or il12p35/ mice failed to give rise to IFN-g
producing effector T cells after viral infection (Figure 4H). Adop-
tively transferred TEMs hardly expanded, as expected (Bou-
neaud et al., 2005). These results demonstrate that simultaneous
stimulation through the TCR, CD28, and IL-12R is necessary for
the development of effector CTLs from both liver-primed T cells
and TCMs during microbial infection.
Liver-Primed T Cells Constitute a Distinct Antigen-
Experienced CD8+ T Cell Population
Our results demonstrate that TCMs and liver-primed T cells are
similar with respect to their antigen-experienced state, localiza-
tion to lymphatic tissues, and activation requirements for gener-
ation of effector CTLs. However, these cells were generated
under fundamentally different situations: TCMs by matured
DCs under inflammatory conditions in lymphatic tissue and
liver-primed T cells under noninflammatory conditions in the
liver. This raised the question how these T cell populations
differed at the molecular level. We therefore compared these
cell populations after FACSorting ex vivo at the global gene
expression level. The global transcriptome was determined in
naive CD8+ OT-I T cells, liver-primed OT-I T cells, and OT-I-
derived TCMs and TEMs obtained >d45 after L.m.-OVA infection
and in exhausted virus-specific CD8+ T cells isolated from mice
suffering from chronic infection with the lymphocytic choriome-
ningitis virus (LCMV). Unbiased principal component analysis
revealed that liver-primed T cells had a distinct gene expression
profile that separated them from memory T cells (Figure 5A).
They were also different from exhausted T cells (Figure 5A),
and their genetic signature also showed no similarities to that
of CD8+ T cells undergoing deletion (Table S1) (Parish et al.,2009). There was a remarkable similarity in the regulation of
genes between T cells primed by LSECs in vitro and those
primed in the chimeric mice in vivo (Figure S5). This supports
the notion that priming of naive T cells in vivo in the chimeric
mouse was indeed performed by LSECs. Priming of naive
CD8+ T cells in vitro by Kupffer cells or liver dendritic cells leads
to T cells with distinct functional and phenotypic properties (data
not shown), further strengthening the point that proliferated
CD44+CD62L+ CD8+ T cells were initially stimulated by LSECs.
In summary, these results establish liver-primed T cells as a
distinct antigen-experienced CD8+ T cell population.
The different global gene expression profile between liver-
primed T cells and TCMs raised the question whether the
observed functional similarities between liver-primed T cells
and TCMs were reflected at the level of gene expression. We
therefore directly compared the core gene expression signature
related to memory T cell function (Wirth et al., 2010) with that of
liver-primed T cells and TCMs. We found that TCMs isolated
>d45 after L.m.-OVA infection showed similar regulation of
approximately 33% of these core memory signature genes
(Table S2). For those genes specifically regulated in TCMs,
a similar regulation was detected in liver-primed T cells for 29
of 68 (43%) upregulated genes and 12 of 30 (40%) downregu-
lated genes (Figure 5B; Table S2). Although these genes were
significantly regulated in liver-primed T cells, their range of regu-
lation was less pronounced compared to TCMs (Figure 5B; Table
S2), indicating that beyond the similarities observed there are
clear differences between these T cell populations.
KEGG pathway analyses using DAVID bioinformatics (Huang
et al., 2009) revealed significant upregulation of the pathways
for cytotoxicity, cytokine signaling, and TCR signaling in TCMs
compared to liver-primed T cells (Table S3). In particular,
TCMs showed upregulation of IFN-g, FASL, and IL-18R1, which
are all related to direct T cell effector function. This suggested
that TCMs, in contrast to liver-primed T cells, directly exert
effector function upon stimulation without the need to first
develop into effector cells. Indeed, TCMs produced IFN-g as
efficiently as TEMs within 4 hr after stimulation with peptide or
PMA/ionomycin (Figure 5C). Moreover, both TCMs and TEMs
showed strong antigen-specific CTL effector function ex vivo
(Figure 5D). As predicted from KEGG pathway analysis liver-
primed T cells neither produced IFN-g nor displayed antigen-
specific CTL effector function upon such stimulation (Figures
5C and 5D), confirming the results obtained in vitro (see Figure 2).
These results demonstrate that unlike memory T cells, liver-
primed T cells are in a distinct differentiation state where they
lack direct CTL effector function but possess TCM-like plasticity
to give rise to effector T cells.
Neuropilin-1 Is a Potential Marker for Liver-Primed
CD8+ T Cells
As conventional markers for identification of antigen-experi-
enced T cells did not suffice to distinguish between TCMs and
liver-primed T cells (see Figure 3), we employed biolayout cluster
analysis from the gene expression profiles of naive T cells,
liver-primed T cells, TCMs, and TEMs to search for markers
specific for liver-primed T cells. We identified clusters that con-
tained 266 genes exclusively regulated in liver-primed T cellsCell Reports 3, 779–795, March 28, 2013 ª2013 The Authors 787
Figure 5. Liver-Primed T Cells Constitute a Distinct Antigen-Experienced CD8+ T Cell Population
(A) Principal component analysis based on most variably expressed genes (n = 671 genes, FDR, p < 0.000005) in naive OT-I T cells (n = 5), OT-I-derived
liver-primed T cells (d4–6 after in vivo priming, n = 6), exhausted LCMV-specific CD8+ T cells (n = 2), and OT-I-derived TCMs (n = 3) or TEMs (n = 3) at d45–60 after
L.m.-OVA infection.
(B) Regulation of TCM-specific genes (see Table S2) in liver-primed T cells. Genes were considered differentially expressed by the following criteria: FC R 2,
p < 0.05, difference of means >100 and passing 10% FDR.
(C and D) CD45.1+ liver-primed T cells (d4 after in vivo priming), TCMs, and TEMs (>d45 postinfection) were FACSorted. (C) Restimulated with peptide or PMA/
ionomycin on CD45.2+ splenic feeder cells, IFN-g production was measured by intracellular staining 4 hr later. (D) Specific cytotoxicity directly ex vivo.
Representative data from at least two experiments with three to four mice per group are shown.
See also Figure S5 and Tables S1, S2, and S3.(Table S4). The highest upregulated genes within these clusters
(>4-fold change in liver-primed T cells compared to naive T cells)
are involved in transcriptional regulation (e.g., Ear2, Zbtb32),
signaling (e.g., axl), cytoskeletal organization (e.g., Anxa2,
Synpo), are expressed as cell-surface molecules (e.g., Fc recep-
tors, Sirpa, Nrp1), or function as transporter molecules (e.g.,
Slc40a1-ferroportin). Our analysis identified Neuropilin-1 (Nrp1)
as the surface molecule with the highest differential expression788 Cell Reports 3, 779–795, March 28, 2013 ª2013 The Authorson liver-primed T cells (Figure 6A; Table S4). Nrp1 was readily
detectable at the protein level on liver-primed T cells with only
very low-level expression on TCMs and TEMs (Figure 6B). This
suggested that Nrp1 staining may be used to differentiate
between liver-primed T cells and TCMs within the total popula-
tion of antigen-experienced T cells. We therefore used this
marker to investigate whether Nrp1+ cells were present among
splenic CD44+CD62L+CD8+ T cells in C57BL/6 mice with a
Figure 6. Nrp1 Is a Marker for Liver-Primed
T Cells
(A) Analysis of Neuropilin-1 (Nrp1) mRNA expres-
sion based on global gene expression data.
(B) Surface staining for Nrp1 on OT-I-derived
TCMs, TEMs, and liver-primed T cells compared
to isotype control (shaded area).
(C) Frequency of Nrp1+ T cells among CD44+
CD62L+CD8+ T cells in the spleen of wild-type
C57BL/6 mice.
(D) Functional characteristics of Nrp1+ and
Nrp1 T cells assessed by IFN-g production in
response to PMA/ionomycin stimulation within
CD44+CD62L+CD8+ T cells obtained from the
spleen of normal mice. Data are representative for
at least two independent experiments.
See also Table S4.normal TCR repertoire. Approximately 3%–5% of these antigen-
experienced CD62L+ T cells expressed Nrp1 (Figure 6C). Similar
to liver-primed T cells, Nrp1+ T cells sorted from splenic
CD44+CD62L+CD8+ T cells in C57BL/6 mice were nonrespon-
siveness to PMA/ionomycin stimulation ex vivo and therefore
lacked direct effector function, whereas Nrp1 T cells
directly produced IFN-g (Figure 6D). While Nrp1 has been
identified as marker for CD4+ T cells with regulatory function
(Bruder et al., 2004; Sarris et al., 2008), expression of Nrp1 on
a particular CD8+ T cell populations has not been reported so
far. Our marker analysis and the functional similarities with
liver-primed T cells indicate that Nrp1 identifies a sizeable pop-
ulation of antigen-experienced CD44+CD62L+CD8+ T cells in
normal mice that was presumably generated from naive T cells
by LSECs.
Liver-Primed T Cells Contribute to Anti-infectious
Immunity
The characteristics of liver-primed T cells reported here raised
the question whether they contribute to anti-infectious immunity.
To monitor antiviral activity of liver-primed T cells, we used a
model where CTL effector function against luciferase-express-
ing target cells in the liver is visualized by a decrease of in vivo
bioluminescence (Stabenow et al., 2010). We adoptively trans-
ferred equal numbers of OT-I-derived liver-primed or (matured)
DC-primed effector CTLs into mice that were infected with re-
combinant adenovirus expressing a fusion protein of OVA and
luciferase. Mice supplied with liver-primed OT-I T cells efficiently
controlled luciferase expression within 7 days (Figures 7A and
7B), which is consistent with development of OVA-specific
effector CTLs from liver-primed T cells that controlled AdOVA
infection in the liver. In contrast, control animals that did
not receive any liver-primed T cells failed to control luciferase
expression. As expected, adoptive transfer of effector OT-I
T cells primed by matured DCs in vitro controlled luciferase
expression even more rapidly (Figures 7A and 7B). Liver-primed
T cells not only controlled viral infection with a replication-defec-
tive adenovirus, but also controlled the bacterial load duringinfection with replication-competent L.m.-OVA (Figure 7C).
These results demonstrate that liver-primed T cells participate
through the generation of effector CTLs in the development of
adaptive immunity against infectious pathogens.
Pathogens can escape innate immunity and some viral infec-
tions cause systemic dissemination of viral antigens in the
absence of concomitant systemic inflammation (Protzer et al.,
2012). It is possible that these pathogens also escape adaptive
immunity as antigen-presentation of pathogen-derived antigens
by immature DCs likely causes deletion of pathogen-specific
T cells. LSEC priming did not induce T cell elimination and
thereby prevented deletion of T cells by immature DCs (see Fig-
ure 1). However, would LSEC priming also render T cells resis-
tant to subsequent deletion by antigen encounter on immature
APCs in a situation of systemic antigen dissemination without
inflammation? To address this issue, we transferred the same
number of naive or liver-primed CD45.1+ OT-I T cells into
C57BL/6 mice and injected DEC205-OVA to induce cross-
presentation by immature DCs. When naive T cells encountered
their antigen on immature DCs, we observed significantly re-
duced T cell numbers after AdOVA challenge (Figure 7D). In
contrast, liver-primed OT-I T cells were not reduced in response
to AdOVA after exposure to immature DCs cross-presenting
OVA (Figure 7D). Thus, priming by LSECs induced a differentia-
tion state in T cells that protects them from deletion during
subsequent antigen encounter on tolerogenic immature DCs.
This led us to further investigate the consequences for antiviral
immunity when systemically distributed antigen is presented first
under noninflammatory conditions to naive CD8+ T cells by either
LSECs or immature DCs. To this end, identical numbers of naive
CD45.1+ OT-I T cells (5 3 105) were transferred into mice where
either LSECs or immature DCs cross-presented OVA (scheme
see Figure S6A). From the spleens of these mice, similar
numbers of total endogenous CD8+ T cells (including proliferated
CD45.1+ cells; Figure S6B) were transferred into RAG2/ recip-
ient mice, which allows us to study the potential of very low
numbers of CD45.1+ T cells to generate antiinfectious immunity
undisturbed from the endogenous TCR repertoire in the recipientCell Reports 3, 779–795, March 28, 2013 ª2013 The Authors 789
Figure 7. Liver-Primed T Cells Contribute to Anti-infectious Immunity
(A and B) liver-primed OT-I cells or OT-I T cells primed by matured DCs were adoptively transferred into congenic C2J mice that were infected with 5 3 105
AdOVA-LUC 1 day before (5 3 105 T cells/mouse). In vivo bioluminescence was determined as a measure of effector T cell function against virus-infected
luciferase-expressing hepatocytes. Representative in vivo bioluminescence images from d5 and d7 postinfection (A) and quantification over time (B).
(C) Effect of 1 3 106 adoptively transferred liver-primed OT-I cells or DC-primed OT-I T cells on bacterial load in liver at d4 after infection with L.m.-OVA.
(D) CD45.1+ naive OT-I T cells (13 105) or liver-primed OT-I T cells were adoptively transferred ex vivo into congenic CD45.2+ recipients that were subsequently
challenged with OVA coupled to anti-DEC205 (DEC205-P3UOrv) or isotype control antibody (ratIgG2a-P3UOrv). Twelve days later, animals were infected with
AdOVA and total numbers of CD45.1+ cells were determined in spleen 5 days postinfection.
(E and F) CD45.1+ OT-I T cells primed under noninflammatory conditions by LSECs or immature DCs in vivo (see Figure S6) were transferred into RAG2/ mice
challenged with AdOVA-LUC 2 days before. Effector T cell function was measured by bioluminescence imaging over time (E) and T cell expansion was deter-
mined in spleen at d13 (F).
Data are representative of at least two independent experiments with three to five mice per group (A–C, E, and F) or pooled from two experiments (D).
See also Figure S6.mouse. Under these conditions, T cells initially primed by imma-
ture DCs failed to show any effect against viral infection, similar
to transfer of T cells from C57BL/6 mice that served as control
(Figure 7E). This is consistent with T cell deletion following
contact with immature DCs. In contrast, initial priming by LSECs
cross-presenting circulating antigen allowed T cells to subse-
quently expand upon re-encounter of antigen during infection
and develop immunity against virus-infected hepatocytes, as
shown by decrease in bioluminescence and massive T cell
expansion in the liver (Figures 7E and 7F). Taken together, our
findings reveal a function of the liver under noninflammatory
conditions in complementing CD8+ T cell immunity generated
during inflammation by matured DCs (see Figure S7).
DISCUSSION
Our results define a memory-like differentiation state in CD8+
T cells primed in the liver that contributes to antimicrobial immu-
nity after reactivation via combinatorial stimulation throughCD28790 Cell Reports 3, 779–795, March 28, 2013 ª2013 The Authorsand IL-12. This distinct T cell differentiation state is induced by
a unique APC population in the liver, i.e., LSECs, which cross-
present circulating antigen that is systemically distributed under
nonimmunogenic conditions. We report that naive T cell stimula-
tion by nonimmune cells can support development of immunity
rather than tolerance, which points to an as-yet-unrecognized
immune function of peripheral organs such as the liver.
The wide expression of immune sensing receptors (e.g., Toll-
like receptors or RIG-I) attributes immune competence also to
nonimmune cells to induce innate immunity and inflammation.
Similar to professional bone-marrow-derived APCs, nonimmune
cells can present antigen to CD8+ T cells, but this is believed to
lead to immune tolerance via T cell deletion or anergy (Bertolino
et al., 1995; Cohen et al., 2010; Fletcher et al., 2010; Gardner
et al., 2008; Redmond et al., 2005). In line with these reports,
we had previously shown that naive CD8+ T cell stimulation by
LSECs cross-presenting circulating antigens results in T cell
nonresponsiveness toward stimulation via the TCR (Diehl et al.,
2008; Limmer et al., 2000). Here, we provide evidence, however,
that liver-primed T cells stimulated by cross-presenting LSECs
are not terminally committed to this nonresponsive state unlike
T cells tolerized toward self-antigens (Schietinger et al., 2012).
Instead, liver-primed T cells are reactivated from their nonre-
sponsive state and like TCMs give rise to effector CTLs in
response to infectious inflammation. This reveals the existence
of a memory-like T cell differentiation state, where cells are non-
responsive toward isolated TCR signaling but have memory-like
functions to develop into effector CTLs upon TCR stimulation in
combination with costimulatory signals vial CD28 and IL-12.
The conditions during which this memory-like T cell differenti-
ation state is induced are fundamentally different from those
required for effector and memory CD8+ T cells generation, which
depend on appropriate DCmaturation via innate immune recep-
tors and subsequent migration to secondary lymphatic tissue
where mature DC cross-prime naive T cells (Zhang and Bevan,
2011). In contrast, liver-primed T cells are generated in the liver
by non-bone-marrow-derived organ-resident LSECs cross-pre-
senting circulating antigen under nonimmunogenic conditions.
Thus, generation of memory-like T cells by LSECs likely comple-
ments effector and memory CD8+ T cell generation during
antigen dissemination without inflammation, which does not
support induction of conventional immunity.
The developmental programs initiated in T cells by antigen-
presenting LSECs or matured DCs differed substantially, which
is reflected by the transient (liver-primed) versus long-term
(mature DC-primed) acquisition of effector cell function and
by their largely different gene expression profiles. However,
common features between memory T cells and liver-primed
T cells are observed. Reduced inflammatory signaling is associ-
ated withmemory rather than terminal effector cell differentiation
(Badovinac et al., 2004, 2005; Cui et al., 2009; Kalia et al., 2010;
Pipkin et al., 2010; Sarkar et al., 2008) and cell-intrinsic regula-
tory STAT3-signaling in CD8+ T cells shields memory precursor
cells from inflammatory signals that induce effector CTL differen-
tiation (Cui et al., 2011). Liver-primed T cells are generated
through stimulatory signaling via the TCR together with little
costimulatory signaling through CD28 in combination with a
balanced and dynamically regulated coinhibitory signaling via
PD1 that antagonizes stimulatory TCR signals after 24 hr (Diehl
et al., 2008; Lohse et al., 1996; Schurich et al., 2010). This
supports the assumption that the short-lived TCR signaling
and little costimulation provided by LSECs contributed to the
induction of the memory-like T cell phenotype similar to memory
T cell generation by short-lived inflammation (Cui and Kaech,
2010). Further similarities exist between liver-primed T cells
and memory T cells. Activation of the Wnt-b-catenin signaling
pathway during T cell activation by matured DCs promotes
memory T cell differentiation and blocks terminal effector cell
differentiation (Gattinoni et al., 2009). From our gene profiling
data, we found TCF1, a transcription factor downstream of the
Wnt-b-catenin signaling pathway that is critical for memory
T cell differentiation (Zhou et al., 2010), to be 50-fold upregulated
in liver-primed T cells compared to T cells primed by matured
DCs. Liver-primed T cells also express molecules known to be
associated with development of memory T cells such as CD27,
IL-7Ra (CD127), IL-2Rb (CD122), and Eomes (Hendriks et al.,
2000; Intlekofer et al., 2005; Kaech et al., 2002a). Liver-primedT cells are KLRG1low, express bcl2 (Diehl et al., 2008), and
respond to IL-15-dependent survival signals, features reported
for TCMs (Harty and Badovinac, 2008). Interestingly, most of
the liver-primed T cells share the same phenotype, indicating
that they form a homogenous T cell population. This is in contrast
to the diverse cell differentiation states induced by matured DCs
during infectious inflammation that give rise to terminal effector
T cells, TCMs, and TEMs (Chang et al., 2007). Taken together,
the development of the distinct CD8+ T cell differentiation state
after priming by LSECs shares many similarities with the devel-
opment ofmemory T cells, although it occurs under nonimmuno-
genic conditions in the liver and is executed by nonprofessional
liver-resident APCs.
Our phenotypic and functional analyses together with global
gene expression profiling and bioinformatic analysis revealed
that liver-primed T cells represent a distinct population of
antigen-experienced CD8 T cells. Antigen-experienced T cells
are grouped into effector T cells andmemory T cells, nonrespon-
sive anergic or exhausted T cells. Liver-primed T cells differ from
effector T cells as they do not express KLRG1 and lack sustained
effector functions. Liver-primed T cells do not respond to stimu-
lation via the TCR or IL-2 and continuously express identical
levels of CD8, which discriminates them from CD8+ T cells that
have become refractory to stimulation (Mescher et al., 2006) or
detuned following recent activation (Xiao et al., 2007). They
further differ at the gene expression level from T cells that were
exhausted after priming during chronic viral infection (Wherry
et al., 2007) and from those undergoing deletion (Parish et al.,
2009). In particular, liver-primed T cells do not express high
levels of PD1 or TIM-3,molecules associated with transcriptional
programming of exhausted T cells (Quigley et al., 2010; Young-
blood et al., 2011). While tolerized T cells remain committed to
their tolerant state (Schietinger et al., 2012) or are deleted (Kurts
et al., 1997), liver-primed T cells survive and can be reactivated.
In summary, liver-primed T cells do not share similarities with
tolerized or exhausted T cells.
Although gene expression profiling showed that liver-primed
T cells are distinct from TCMs and TEMs, liver-primed T cells
share more than 40% of similarity with the core gene expression
signature of TCMs and show several memory-like functions.
Liver-primed T cells express the lymphoid homing molecule
CD62L and respond to chemotactic signals through CCR7.
Conversely, liver-primed T cells did not express the molecule
CD103 that is found on nonmigratory tissue memory T cells
(Jiang et al., 2012; Sheridan and Lefranc¸ois, 2011). Similar to
TCMs (Kaech and Wherry, 2007; Williams and Bevan, 2007),
liver-primed T cells locate to T cell zones in secondary lymphatic
organs in vivo, where they are exposed to antigen-presenting
DCs. A key feature of TCMs is their ability to give rise to effector
CTLs upon reactivation. Liver-primed T cells also generate recall
responses and give rise to fully functional effector CTLs, which
requires concomitant signaling via the TCR, CD28, and IL-12.
Surprisingly, TCMs require the same combinatorial signaling to
generate recall responses, which suggests that inflammation-
induced DCmaturation is necessary to induce the large numbers
of effector CTLs from the pool of TCMs and liver-primed
T cells, which is required to provide protection against infecting
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LSECs do not discriminate between foreign or autoantigens
for antigen presentation to CD8 T cells; nevertheless, the
memory-like differentiation state in liver-primed T cells is unlikely
to cause autoimmunity. The reactivation of liver-primed T cells
requires combinatorial signaling via TCR/CD28 and IL-12, which
can only be delivered by professional APCs matured during
infectious inflammation. Thus, the requirements for induction of
immunity against autoantigens are equally high as for naive
T cells. Furthermore, liver-primed T cells differ from TCMs by
not responding to TCR stimulation with direct cytokine produc-
tion or cytotoxic effector function. This particular feature of
liver-primed T cells can be mistaken for a sign of ‘‘tolerance’’
in situations where the cognate antigen is recognized in the
absence of costimulatory signals, but thismay provide additional
safety against development of autoimmunity.
As conventional T cell activation and memory markers could
not discriminate TCMs from liver-primed T cells, we sought to
identify a molecular marker to identify these cells in the normal
T cell repertoire of wild-typemice. In a detailed biolayout analysis
of the global gene expression profiles, we found Neuropilin 1
(Nrp1) as the cell surface molecule with the largest difference
in gene expression that separated liver-primed T cells from
TCMs also at the protein level. Murine regulatory T cells and
IL-17-producing NKT cells also express Nrp1 that mediates
cell-cell contact through homotypic interaction (Bruder et al.,
2004). Although Nrp1 is expressed on recently activated CD8+
T cells (Kaech et al., 2002a), the expression levels of CD62L
allowed us to distinguish recently activated or effector CTLs
(CD62Llow) from liver-primed T cells (CD62Lhi). Whether Nrp1
expression on liver-primed T cells is functionally relevant for their
unique differentiation state requires further investigation, but it is
known that Nrp1 increases hedgehog signaling (Hillman et al.,
2011) and that hedgehog signaling mitigates activation via the
TCR (Crompton et al., 2007). In normal mice, approximately
5% of antigen-experienced CD44+CD62LhiCD8+ T cells express
Nrp1 and fail to respond to TCR stimulation, whereas CD44+
CD62LhiCD8+ Nrp1neg T cells, i.e., TCMs, produce IFN-g. This
suggests that liver-primed T cells constitute a substantial pro-
portion of antigen-experienced T cells under physiological con-
ditions and may serve to support immune responses against
infectious microorganisms.
It is an unresolved issue how adaptive immunity is generated
when systemic distribution of microbial antigens, such as
surface or structural viral antigens that do not trigger innate
immunity and inflammation, leads to antigen-presentation by
immature DCs, which can cause cross-tolerance of pathogen-
specific T cells. Here, we demonstrate that priming by LSECs
can rescue naive T cells from deletion by immature DCs and
also spares them from cross-tolerance upon re-encounter with
antigen on immature DCs. We propose that T cell priming by
LSECs in the liver protects from attrition of the T cell repertoire
in situations where professional APCs fail to promote T cell
survival or differentiation into memory T cells, such as systemic
distribution of antigens in the absence of inflammation. This
may occur during viral infection of the liver by hepatotropic
viruses such as hepatitis B virus or hepatitis C virus, that cause
infection in approximately 50%of theworld’s population (Protzer
et al., 2012). In the experiments performed here, effector CTLs792 Cell Reports 3, 779–795, March 28, 2013 ª2013 The Authorsgenerated during recall responses arising from liver-primed
T cells during infectious inflammation controlled bacterial and
viral infection. Liver-primed T cells may thus contribute to
immune control of bacteria colonizing the body surfaces,
because immune responses against these bacteria are readily
induced once they enter the body (Duerkop et al., 2009). Thus,
T cell priming by LSECs may form a ‘‘prealert’’ state where
conservation of T cells from deletion or tolerance preempts
infections with pathogens that have not entered the body yet
or have escaped innate immune sensing.
The survival of liver-primed T cells under noninflammatory
conditions and their memory-T-cell-like function to give rise to
effector CTLs controlling pathogen infection is evidence that
organ-resident APCs, which are not derived from the bone
marrow, contribute to antipathogen immunity. Generation of
liver-primed T cells may precede or complement the generation
of effector and memory T cells during the early phases of infec-
tion, which then allows the host to mount specific T cell immunity
upon re-encounter with infectious pathogens under inflamma-
tory conditions. The understanding of this T cell differentiation
state may be harnessed therapeutically, for instance, to specifi-
cally activate liver-primed T cells to overcome chronic viral infec-
tion of the liver.
EXPERIMENTAL PROCEDURES
Cell Isolation and Coculture Experiments
Naive CD8+ T cells or dendritic cells were isolated from spleen and purified by
autoMACS (Miltenyi Biotec). LSECs were isolated by gradient centrifugation
followed by immunomagnetic sorting (CD146) (Diehl et al., 2008). Cocultures
of naive T cells with LSECs or matured DCs were conducted as described
previously (von Oppen et al., 2009). Briefly, OT-I T cells were added to LSECs
or matured DCs previously loaded with 100 mg/ml OVA; OT-I to antigen-
presenting cell ratio 1:1. Matured DCs were obtained from spleen of mice in-
jected with 100 mg CpG 1668 4 hr before isolation. In some experiments,
neutralizing antibodies for IL-12 (anti-mouse IL-12, clone C17.8) or type I IFN
signaling (anti-mouse IFNAR1, clone MAR1-5A3) were added to cocultures
at 10 mg/ml. H-2Kb-restricted SIINFEKL-specific B3Z cells were used to detect
cross-presentation in vitro by determining IL-2 release from T cells by ELISA.
Animal experiments performed were approved by the local authorities in
Northrhine-Westphalia.
Generation and Analysis of OT-I Memory T Cells
Low, physiological numbers (5 3 102) (Marzo et al., 2005) of CD45.1+ or
CD90.1+ OT-I T cells were adoptively transferred into sex-matched CD45.2+
CD90.2+ C57BL/6 recipient mice. One day later, mice were infected with
5 3 103 colony forming units (cfu) L.m.-OVA by i.p. injection. The course of
the OT-I T cell response identified by the respective congenic marker
CD45.1/CD90.1 was followed in blood over time. Memory T cells were ob-
tained at d45–d70 postinfection from spleen if not indicated otherwise.
Memory OT-I cells were identified by expression of the respective congenic
marker CD45.1 or CD90.1 in conjunction with a CD8+CD44+CD127+ pheno-
type. TCMs (CD62L+) and TEMs (CD62L) were distinguished by CD62L
expression. For functional analysis or adoptive transfer experiments, TCMs
and TEMs were isolated from spleen by enrichment with autoMACS
(untouched CD8 T cell isolation kit, Miltenyi) followed by FACS sorting for their
respective markers. TCMs and TEMs obtained from the same animals were
used as controls.
Infection with Listeria monocytogenes OVA
Mice were infected i.p. with Listeria monocytogenes expressing OVA (L.m.-
OVA) or with wild-type Listeria monocytogenes (wt L.m.) acquired from log
phase of growth in BHI medium. cfu (5 3 103) were used for analysis of
T cell responses and to generate memory T cells; 5 3 104 cfu for analysis of
bacterial load in liver.
Bioluminescence Measurement In Vivo
Measurement of bioluminescence in livers of C2J or RAG2/ mice was
performed each day postinfection with AdOVALUC as described previously
(Stabenow et al., 2010). In brief, bioluminescence was analyzed with an IVIS
200 system (Caliper LifeSciences) 5 min. after i.p. injection of Luciferin
(50mM, Caliper LifeSciences) in PBS. Data analysis was performedwith Living
Image 2.50.1 software (Caliper LifeSciences).
Fluorochrome Labeling of T Cells and Immunofluorescence
T cells were labeled with 1 mM CFSE (Invitrogen) or 5 mM FarRed DDAO-SE
(7-hydroxy-9H-[1,3-dichloro-9,9-dimethylacridin-2-one], succinimidyl ester;
Invitrogen) for 15min at 37C. T cell zoneswere visualized by staining with fluo-
rochrome-conjugated anti-CD3ε (500A2; BD). Sections were viewed with an
Olympus IX71 with a 103 objective. Images were captured, and fluorescently
labeled T cells per mm2 T cell area were counted with Cell F software
(Olympus). For quantification of labeled T cell numbers in the T cell zones
within spleen and lymph nodes, 10–20 T cell zones were quantified for each
animal.
T Cell Migration
Chemotaxis of CD8+ T cells was quantified using transwell migration assays.
Liver-primed, DC-primed, or naive OT-I cells (2 3 105 cells in 300 ml RPMI/
0.5% FCS) were loaded in triplicates into 5 mm pore-size polycarbonate trans-
well inserts (Costar, Corning). CCL19 (100 ng/ml; Peprotech) or CCL21
(200 ng/ml; Peprotech) was added to 700 ml RPMI/0.5% FCS in the lower
compartment. Control assays were performed without chemokine. Transmi-
grated cells were counted after 4 hr of incubation at 37C.
Analysis of T Cell Function
In vitro, T cell stimulation was done with plate-bound aCD3 antibody
(145.2C11), aCD3/CD28 microbeads (Invitrogen), or PMA (5 ng/ml; Sigma
Aldrich) and ionomycin (200 ng/ml, Sigma). In some experiments, the cyto-
kines IL-2 (5–20 ng/ml), IL-7 (5–20 ng/ml), IL-15 (5–20 ng/ml), IL-12 (0.5–
5 ng/ml), IL-23 (5–20 ng/ml), TNF (5–20 ng/ml), IL-6 (5–20 ng/ml), IFN-g
(550 ng/ml), or IFN-a (type 4, 500–2,000 U/ml) were added to T cell stimula-
tion assays. Restimulation of OT-I-derived liver-primed T cells or memory
T cells after FACSorting was performed in coculture with CD45.2+CD90.2+
splenocytes as feeder cells with PMA/ionomycin or SIINFEKL peptide
(0.5 mM) for 4 hr in the presence of Brefeldin A and Monensin (eBioscience).
To analyze T cell proliferation, naive CD8+ T cells were labeled with 1 mM
CFSE (Invitrogen) before coculture experiments or adoptive transfer. CFSE
dilution was measured by flow cytometry compared to unstimulated controls.
Alternatively, EdU (5-ethynyl-20-deoxyuridine, 10 mM) was added for a 20 hr
stimulation period and subsequently detected by Click-iT EdU Alexa Fluor
488 Cell Proliferation Assay Kit (Invitrogen) according to the manufacturer’s
protocol. Gating on EdU+ cells was performed on living T cells in comparison
to identical control groups stimulated in the absence of EdU. Specific cytotox-
icity was determined in vitro as described (Diehl et al., 2008). LPS-free
Ovalbumin (Hyglos) was used for in vivo experiments at a concentration of
500 mg/mouse. For analysis of proliferation by BrdU incorporation in vivo,
mice were injected with 1.5 mg BrdU i.p. 20 hr before analysis.
Coupling of DEC205 to P3UOrv
In brief, anti-DEC205 antibody (NLDC-145) or isotype control antibody was
coupled to the fusion protein of three protein G domains and ovalbumin
(P3UOrv) at 4C in PBS, as described (Kratzer et al., 2010). Antibody/fusion
protein complexes (DEC205-P3UOrv) (1.3 mg) were injected i.p. into mice.
Statistical Analysis
If not indicated otherwise, the unpaired two-tailed Student’s t test was used
for data comparisons. Data are shown as mean ± SEM or mean ± SD with
*p < 0.05, **p < 0.01, ***p < 0.001.
For further details, please refer to Extended Experimental Procedures.ACCESSION NUMBERS
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